Related Experiment Video
Updated: Aug 10, 2026
Construction of a Preclinical Multimodality Phantom Using Tissue-mimicking Materials for Quality Assurance in Tumor Size Measurement
Published on: July 29, 2013
Tumor size on computed tomography scans: is one measurement enough?
A H Dachman1, P M MacEneaney, A Adedipe
1Department of Radiology, Pritzker School of Medicine, The University of Chicago, IL 60637, USA. ahdachma@midway.uchicago.edu
Background:
Bidimensional tumor measurements are used routinely as surrogates for tumor volume. The purpose this study was to determine whether there is any added benefit in bidimensional or tridimensional measurements over a unidimensional measurement.
Methods:
Sixty-nine colorectal hepatic metastases on 19 computed tomography scans (1-8 lesions per scan) from 9 patients were analyzed. Five patients contributed 2-4 scans each (mean, 3 scans). The standard volume of these lesions was determined by the "summation of areas" technique. The maximum axial dimension, the product of the greatest axial dimensions, and several volume estimates (based on the volumes of a sphere, an ellipsoid, and a cube) each were correlated with the standard volume.
Results:
The maximum axial dimension and the product of the greatest axial dimensions correlated equally with tumor volume (correlation coefficient = 0.93). Surrogate measures based on the equations for a sphere and an ellipsoid underestimated tumor volume, whereas the equation for a cube overestimated volume.
Conclusions:
When reporting tumor size, there is no significant added benefit in reporting bidimensional or tridimensional measurements over the maximum axial dimension.
